combretastatin has been researched along with paclitaxel in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kajiyama, S; Kobayashi, A | 1 |
| Day, BW; Hamel, E; Rosenkranz, HS; ter Haar, E | 1 |
| Lee, AE; McKeage, MJ; Pruijn, FB; Shalal-Zwain, S; Siim, BG; Wilson, WR | 1 |
| Edelman, MJ | 1 |
| Dall'Acqua, S | 1 |
| Alain, T; Chambers, J; Côté, M; Cui, J; D'Costa, VM; Ekker, M; El-Sahli, S; Farah, E; Gadde, S; Hua, K; Lee, SH; Li, L; Li, X; Liu, D; McGarry, S; Sulaiman, A; Wang, L; Zheng, P | 1 |
| Kumar, D; Kumar, S; Sharma, P; Shri, R | 1 |
4 review(s) available for combretastatin and paclitaxel
| Article | Year |
|---|---|
[Molecular basis of probes for cytoskeletal proteins].
Topics: Animals; Bibenzyls; Colchicine; Cytoskeletal Proteins; Fertilization; Microtubules; Mitosis; Paclitaxel; Sea Urchins; Stilbenes; Zearalenone | 1993 |
Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer.
Topics: Antineoplastic Agents; Bibenzyls; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Resistance, Neoplasm; Epothilones; Humans; Lung Neoplasms; Paclitaxel; Polyglutamic Acid; Tubulin Modulators; Vinblastine; Vinorelbine | 2009 |
Natural products as antimitotic agents.
Topics: Antimitotic Agents; Antineoplastic Agents; Bibenzyls; Biological Products; Humans; Ligands; Microtubules; Neoplasms; Paclitaxel; Protein Binding; Structure-Activity Relationship; Tubulin; Vinca Alkaloids | 2014 |
Mechanistic Insights and Docking Studies of Phytomolecules as Potential Candidates in the Management of Cancer.
Topics: Antineoplastic Agents; Bibenzyls; Colchicine; Curcumin; Humans; Molecular Docking Simulation; Neoplasms; Paclitaxel | 2022 |
3 other study(ies) available for combretastatin and paclitaxel
| Article | Year |
|---|---|
Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
Topics: Antineoplastic Agents, Phytogenic; Bibenzyls; Binding Sites; Colchicine; Models, Molecular; Paclitaxel; Podophyllotoxin; Protein Conformation; Software; Stilbenes; Tubulin; Tubulin Modulators | 1996 |
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Carboplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Stilbenes; Time Factors; Xanthenes; Xanthones | 2003 |
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature.
Topics: Animals; Apoptosis; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Combinations; Female; Humans; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Rats; Triple Negative Breast Neoplasms; Verteporfin; Zebrafish | 2021 |